122 related articles for article (PubMed ID: 2409872)
1. Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia.
Nienhuis AW; Ley TJ; Humphries RK; Young NS; Dover G
Ann N Y Acad Sci; 1985; 445():198-211. PubMed ID: 2409872
[No Abstract] [Full Text] [Related]
2. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
Fathallah H; Sutton M; Atweh GF
Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
[TBL] [Abstract][Full Text] [Related]
3. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
Dover GJ; Charache S; Nora R; Boyer SH
Ann N Y Acad Sci; 1985; 445():218-24. PubMed ID: 2409873
[No Abstract] [Full Text] [Related]
4. Induction of hemoglobin F synthesis in patients with beta thalassemia.
Ley TJ; Nienhuis AW
Annu Rev Med; 1985; 36():485-98. PubMed ID: 2581500
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia.
Platt OS
Am J Pediatr Hematol Oncol; 1985; 7(3):258-60. PubMed ID: 2416231
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors.
Cao H
Hematology; 2004 Jun; 9(3):223-33. PubMed ID: 15204104
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of fetal hemoglobin in patients with beta-thalassemia.
Olivieri NF
Semin Hematol; 1996 Jan; 33(1):24-42. PubMed ID: 8714583
[No Abstract] [Full Text] [Related]
8. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
Pearson HA
Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
[No Abstract] [Full Text] [Related]
9. Augmentation of hemoglobin synthesis by S-phase specific drugs in the K562 cell line.
Dean A; Wu YJ; Ley T; Fordis CM; Schechter AN
Prog Clin Biol Res; 1985; 191():205-16. PubMed ID: 2413473
[No Abstract] [Full Text] [Related]
10. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment.
Singer ST; Kuypers FA; Olivieri NF; Weatherall DJ; Mignacca R; Coates TD; Davies S; Sweeters N; Vichinsky EP
Ann N Y Acad Sci; 2005; 1054():250-6. PubMed ID: 16339672
[TBL] [Abstract][Full Text] [Related]
11. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
Dover GJ; Charache S; Boyer SH
Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
[No Abstract] [Full Text] [Related]
12. Pharmacologic manipulation of fetal hemoglobin synthesis.
Dover GJ; Humphries RK; Young N; Ley T; Boyer S; Charache S; Nienhuis A
Prog Clin Biol Res; 1985; 191():447-54. PubMed ID: 2413480
[TBL] [Abstract][Full Text] [Related]
13. Approaches to the reactivation of hemoglobin F as a treatment for sickle cell disease.
DeSimone J
Clin Adv Hematol Oncol; 2004 Jan; 2(1):23-4. PubMed ID: 16163154
[No Abstract] [Full Text] [Related]
14. 5-azacytidine for beta-thalassaemia?
Lancet; 1983 Jan; 1(8314-5):36-7. PubMed ID: 6184580
[No Abstract] [Full Text] [Related]
15. 5-azacytidine for beta thalassaemia?
Ley TJ; Anagnou NP; Young NS; Nienhuis AW; DeSimone J; Heller P
Lancet; 1983 Feb; 1(8322):467. PubMed ID: 6186873
[No Abstract] [Full Text] [Related]
16. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
Yang YM; Pace B
Pediatr Pathol Mol Med; 2001; 20(1):87-106. PubMed ID: 12673846
[TBL] [Abstract][Full Text] [Related]
17. The role of fetal hemoglobin-enhancing agents in thalassemia.
Lal A; Vichinsky E
Semin Hematol; 2004 Oct; 41(4 Suppl 6):17-22. PubMed ID: 15534853
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
Stamatoyannopoulos JA; Nienhuis AW
Annu Rev Med; 1992; 43():497-521. PubMed ID: 1374600
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin switching protocols in thalassemia. Experience with sodium phenylbutyrate and hydroxyurea.
Dover GJ
Ann N Y Acad Sci; 1998 Jun; 850():80-6. PubMed ID: 9668530
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic manipulation of fetal hemoglobin. Update on clinical trials with hydroxyurea.
Dover GJ
Ann N Y Acad Sci; 1990; 612():184-90. PubMed ID: 1705407
[No Abstract] [Full Text] [Related]
[Next] [New Search]
